INCR
INCR
NASDAQ · Pharmaceuticals

Intercure Ltd

$0.73
-0.02 (-2.68%)
As of Mar 25, 4:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
900.48M
Net Income
-255,594,057
Gross Margin
14.9%
Profit Margin
-28.4%
Rev Growth
+2.8%
D/E Ratio
0.51
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 14.9% 14.9% 42.1% 42.1%
Operating Margin -28.1% -25.3% 25.4% 23.5%
Profit Margin -28.4% -27.0% 18.6% 18.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 900.48M 875.69M 56.95M 44.24M
Gross Profit 134.17M 130.48M 23.96M 18.61M
Operating Income -253,394,000 -221,778,274 14.46M 10.41M
Net Income -255,594,057 -223,703,832 10.61M 8.30M
Gross Margin 14.9% 14.9% 42.1% 42.1%
Operating Margin -28.1% -25.3% 25.4% 23.5%
Profit Margin -28.4% -27.0% 18.6% 18.8%
Rev Growth +2.8% +2.8% -4.9% +12.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 22.43M 22.43M 21.12M 16.64M
Total Equity 44.06M 44.06M 85.08M 101.00M
D/E Ratio 0.51 0.51 0.25 0.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -181,457,946 -167,640,813 17.54M 14.43M
Free Cash Flow 14.62M 7.88M